-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下：加拿大太平洋铁路公司（CP）公布第一季度调整后每股收益为1.04美元，超出市场预期0.26美元。尽管每千英里货运量（RTM）增长2%，但由于价格压力导致每千英里货运量收入下降4%，总收入仍下降2%至37亿美元。营业收入下降4%至13亿美元，营业比率上升70个基点至66.0%，反映了持续的堪萨斯城南方铁路公司（KCS）整合成本，其中包括9100万美元的收购会计摊销。尽管受整体经济形势影响，短期内货运量受到限制，但该公司2万英里的跨大陆铁路网络仍为其提供了竞争优势。运营方面，CP展现出更佳的网络流畅性：平均列车速度提高4%至19.9英里/小时，终端停留时间缩短8%至9.5小时，机车生产率提高5%。各业务线表现参差不齐。由于加拿大粮食产量强劲，粮食收入增长 11% 至 8.71 亿美元，而工业部门则面临反映市场疲软的逆风：能源、化工和塑料下降 8% 至 7 亿美元，煤炭下降 12% 至 2.26 亿美元。
Related Articles
Asia
Electro Optic Systems Reports Contract Backlog Growth as of March 31
Electro Optic Systems Holdings (ASX:EOS) reported a contract backlog of AU$518 million as of March 31, up 13% from the end of 2025, according to a Thursday filing with the Australian bourse.The company closed the March quarter with unrestricted cash holdings of AU$95.1 million, representing a decrease of AU$11.8 million from the end of 2025, per the filing.
$ASX:EOS
Asia
Regis Healthcare Expects Fiscal 2026 Underlying EBITDA at Top End of Guidance
Regis Healthcare (ASX:REG) said it expects fiscal 2026 underlying earnings before interest, taxes, depreciation, and amortization (EBITDA) of about AU$135 million, at the top end of guidance, according to a Thursday Australian bourse filing.Occupancy across mature homes averaged about 96% in the fiscal third quarter, per the filing.The company said it generated net refundable accommodation deposit (RAD) cash inflows of AU$44.5 million in the third quarter, taking the total net RAD cash inflows for the year to date to AU$223 million.As resident turnover occurs, the progressive repricing of existing paid-up RADs to current advertised room prices is expected to generate net operating cash inflows of about AU$400 million over time while also increasing RAD retention earnings, the company added.
$ASX:REG
Research
Research Alert: CFRA Keeps Hold Opinion On Shares Of Mondelez International
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price of $63, raised $1, reflects a 19x multiple of projected 2027 EPS, in line with MDLZ's historical forward P/E average. We raise our 2026 EPS estimate by $0.06 to $3.08, but cut 2027's by $0.11 to $3.32. We continue to see headwinds related to chocolate and biscuits divisions, though favorable forex has been helping to a degree. MDLZ highlighted plans to stimulate growth with more promotional activity, which could boost revenues (we see an acceleration in revenues in 2027), but may come with the trade-off of narrower margins. We note that cost-saving efforts can also contribute to staving off some of the margin pressure. MDLZ is largely hedged on its cocoa input costs for 2026 but less so in 2027. Thus, if the substantial rise in cocoa pricing in 2025 does not reemerge, it should help the bottom line in 2027 as cost pressures should ease. Share buybacks have also contributed to EPS, and we note that Q1 2026 share count was down 1.5% from one year earlier.
$MDLZ